Modulation of Vaccine-Induced CD4 T Cell Functional Profiles by Changes in Components of HIV Vaccine Regimens in Humans (Q59352780)

15

Nelson L Michael

0 references

Jerome H Kim

14

Jerome H Kim

0 references

Supachai Rerks-Ngarm

9

Supachai Rerks-Ngarm

0 references

Hendrik Streeck

16

Hendrik Streeck

0 references

Galit Alter

12

Galit Alter

0 references

Mary A Marovich

6

Mary Marovich

0 references

Michael A Eller

3

Michael A Eller

0 references

Punnee Pitisuttithum

10

Punnee Pitisuttithum

0 references

Somchai Sriplienchan

8

Somchai Sriplienchan

0 references

Silvia Ratto-Kim

5

Silvia Ratto-Kim

0 references

Bruce Schultz

4

Bruce T Schultz

0 references

Franco Pissani

1

Franco Pissani

0 references

author name string

Bianca Schulte

2

0 references

Prasert Thongcharoen

7

0 references

Stefan Esser

T-cell responses induced in normal volunteers immunized with a DNA-based vaccine containing HIV-1 env and rev

11

0 references

language of work or name

English

0 references

publication date

1 December 2018

0 references

published in

Journal of Virology

0 references

volume

92

0 references

issue

23

0 references

cites work

1 reference

12 December 2020

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

1 reference

12 December 2020

Safety and immunogenicity of combinations of recombinant subtype E and B human immunodeficiency virus type 1 envelope glycoprotein 120 vaccines in healthy Thai adults.

1 reference

12 December 2020

Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines

1 reference

12 December 2020

Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults.

1 reference

12 December 2020

Poxvirus-based vaccine candidates for HIV: two decades of experience with special emphasis on canarypox vectors

1 reference

12 December 2020

Cytotoxic T-lymphocyte responses to canarypox vector-based HIV vaccines in HIV-seronegative individuals: a meta-analysis of published studies

1 reference

12 December 2020

Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial

1 reference

12 December 2020

Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses

1 reference

12 December 2020

A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost.

1 reference

12 December 2020

Vaccines: correlates of vaccine-induced immunity

1 reference

12 December 2020

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

1 reference

12 December 2020

Comparative cell-mediated immunogenicity of DNA/DNA, DNA/adenovirus type 5 (Ad5), or Ad5/Ad5 HIV-1 clade B gag vaccine prime-boost regimens

1 reference

12 December 2020

A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172).

1 reference

12 December 2020

Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidate

1 reference

12 December 2020

Current progress in the development of a prophylactic vaccine for HIV-1.

1 reference

12 December 2020

Targeting of HIV-p24 particle-based vaccine into differential skin layers induces distinct arms of the immune responses

1 reference

12 December 2020

Multiple stained samples are not appropriate compensation controls.

1 reference

12 December 2020

A double-blind randomized phase I clinical trial targeting ALVAC-HIV vaccine to human dendritic cells

1 reference

12 December 2020

Intradermal immunization triggers epidermal Langerhans cell mobilization required for CD8 T-cell immune responses

1 reference

12 December 2020

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

1 reference

12 December 2020

Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production

1 reference

12 December 2020

Emerging concepts on T follicular helper cell dynamics in HIV infection

1 reference

12 December 2020

Enhanced immunogenicity of an HIV-1 DNA vaccine delivered with electroporation via combined intramuscular and intradermal routes

1 reference

12 December 2020

Heterologous prime-boost vaccination with MF59-adjuvanted H5 vaccines promotes antibody affinity maturation towards the hemagglutinin HA1 domain and broad H5N1 cross-clade neutralization

1 reference

12 December 2020

Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1.

1 reference

12 December 2020

COMPASS identifies T-cell subsets correlated with clinical outcomes

1 reference

12 December 2020

Circulating HIV-Specific Interleukin-21(+)CD4(+) T Cells Represent Peripheral Tfh Cells with Antigen-Dependent Helper Functions

1 reference

12 December 2020

New developments in an old strategy: heterologous vector primes and envelope protein boosts in HIV vaccine design.

1 reference

12 December 2020

A Cytokine-Independent Approach To Identify Antigen-Specific Human Germinal Center T Follicular Helper Cells and Rare Antigen-Specific CD4+ T Cells in Blood.

1 reference

12 December 2020

Direct Probing of Germinal Center Responses Reveals Immunological Features and Bottlenecks for Neutralizing Antibody Responses to HIV Env Trimer

1 reference

12 December 2020

Progress in HIV vaccine development

1 reference

12 December 2020

Randomized, Double-Blind Evaluation of Late Boost Strategies for HIV-Uninfected Vaccine Recipients in the RV144 HIV Vaccine Efficacy Trial

1 reference

12 December 2020

Critical Role for Skin-Derived Migratory DCs and Langerhans Cells in TFH and GC Responses after Intradermal Immunization

1 reference

12 December 2020

Preservation of Peripheral T Follicular Helper Cell Function in HIV Controllers

1 reference

12 December 2020

Intradermal HIV-1 DNA immunization using needle-free Zetajet<sup>TM</sup> injection followed by HIV-modified vaccinia virus Ankara vaccination is safe and immunogenic in Mozambican young adults: a phase I randomized controlled trial.

1 reference

12 December 2020

First-in-Human Randomized Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector.

1 reference

12 December 2020